Ad
related to: lumiradx sars-cov-2 ag test
Search results
Lower COVID-19 Testing Revenues Hit LumiraDx Q2, Plans Cost Cutting Initiatives
Benzinga via Yahoo Finance· 2 years agoLumiraDx Limited's (NASDAQ: LMDX) Q2 FY22 sales reached $44.7 million compared to Q1 2022 revenue of...
